ANGPTL3 and hypertriglyceridemia: Both ANGPTL3 and ANGPTL8 interact as regulators of LPL activity, and both are targets for pharmacotherapeutic agents currently undergoing testing as potentially effective drugs in the treatment of hypertriglyceridemia.